South China Morning Post World
Mainland China Funds Boost Stakes in Hong Kong Biotech Amid Licensing Deal Surge
Mainland Chinese institutional investors are increasing their holdings in Hong Kong-listed biotechnology firms, attracted by favorable valuations and a rise in cross-border licensing agreements.